Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations

• Kristin Palmsten ,

  * E-mail: kkp762@mail.harvard.edu

  Affiliation Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Krista F. Huybrechts,

  Affiliation Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Helen Mogun,

  Affiliation Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Mary K. Kowal,

  Affiliation Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Paige L. Williams,

  Affiliation Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Karin B. Michels,

  Affiliations Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America, Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, Institute for Prevention and Cancer Epidemiology, University of Freiburg Medical Center, Freiburg, Germany

  ⨯
• Soko Setoguchi,

  Affiliations Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Sonia Hernández-Díaz

  Affiliation Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯